Shares of Antibe Therapeutics Inc. (OTCMKTS:ATBPD – Get Rating) were up 4.5% on Tuesday . The company traded as high as $0.40 and last traded at $0.40. Approximately 811 shares were traded during trading, a decline of 97% from the average daily volume of 29,710 shares. The stock had previously closed at $0.38. Antibe Therapeutics […]
Antibe Therapeutics Inc. (OTCMKTS:ATBPF – Get Rating) was down 4% on Monday . The stock traded as low as $0.38 and last traded at $0.38. Approximately 1,770 shares traded hands during mid-day trading, a decline of 83% from the average daily volume of 10,186 shares. The stock had previously closed at $0.40. Antibe Therapeutics Price […]
Antibe Therapeutics Inc. (TSE:ATE – Get Rating) shares crossed below its 50-day moving average during trading on Monday . The stock has a 50-day moving average of C$0.55 and traded as low as C$0.52. Antibe Therapeutics shares last traded at C$0.52, with a volume of 54,350 shares traded. Antibe Therapeutics Stock Performance The company has […]
Antibe Therapeutics Inc. (TSE:ATE – Get Rating)’s stock price passed above its 50 day moving average during trading on Wednesday . The stock has a 50 day moving average of C$0.56 and traded as high as C$0.64. Antibe Therapeutics shares last traded at C$0.61, with a volume of 8,631 shares traded. Antibe Therapeutics Stock Performance […]
Antibe Therapeutics Inc. (TSE:ATE – Get Rating) rose 8.9% during trading on Wednesday . The stock traded as high as C$0.61 and last traded at C$0.61. Approximately 103,767 shares changed hands during mid-day trading, an increase of 173% from the average daily volume of 38,071 shares. The stock had previously closed at C$0.56. Antibe Therapeutics […]